SMMT Summit Therapeutics RESULTS: Q2, Q2 EPS $-0.28, Q2 Net Income $-215.7M, Q2 operating expenses $220.5M
SMMT Summit Therapeutics RESULTS: Q2, Q2 EPS $-0.28, Q2 Net Income $-215.7M, Q2 operating expenses $220.5M
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.